PolyPid Ltd. (PYPD)
6.53
-0.01
(-0.15%)
USD |
NASDAQ |
Nov 18, 16:00
6.79
+0.26
(+3.98%)
After-Hours: 20:00
PolyPid Enterprise Value : 123.72M for Nov. 17, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 17, 2026 | 123.72M |
| November 16, 2026 | 115.48M |
| November 13, 2026 | 117.80M |
| November 12, 2026 | 120.76M |
| November 11, 2026 | 124.99M |
| November 10, 2026 | 118.86M |
| November 09, 2026 | 117.38M |
| November 06, 2026 | 115.27M |
| November 05, 2026 | 105.34M |
| November 04, 2026 | 108.51M |
| November 03, 2026 | 100.90M |
| November 02, 2026 | 100.06M |
| October 30, 2026 | 99.42M |
| October 29, 2026 | 103.65M |
| October 28, 2026 | 107.66M |
| October 27, 2026 | 107.45M |
| October 26, 2026 | 97.31M |
| October 23, 2026 | 96.47M |
| October 22, 2026 | 93.93M |
| October 21, 2026 | 92.66M |
| October 20, 2026 | 94.35M |
| October 19, 2026 | 88.65M |
| October 16, 2026 | 85.27M |
| October 15, 2026 | 89.07M |
| October 14, 2026 | 87.59M |
| Date | Value |
|---|---|
| October 13, 2026 | 88.65M |
| October 12, 2026 | 91.61M |
| October 09, 2026 | 92.66M |
| October 08, 2026 | 89.07M |
| October 07, 2026 | 90.13M |
| October 06, 2026 | 93.93M |
| October 05, 2026 | 95.41M |
| October 02, 2026 | 95.20M |
| October 01, 2026 | 99.00M |
| September 30, 2026 | 96.89M |
| September 29, 2026 | 102.25M |
| September 28, 2026 | 102.66M |
| September 25, 2026 | 100.83M |
| September 24, 2026 | 103.67M |
| September 23, 2026 | 101.85M |
| September 22, 2026 | 105.50M |
| September 21, 2026 | 99.81M |
| September 18, 2026 | 100.63M |
| September 17, 2026 | 96.97M |
| September 16, 2026 | 100.63M |
| September 15, 2026 | 99.61M |
| September 14, 2026 | 103.06M |
| September 11, 2026 | 99.41M |
| September 10, 2026 | 99.61M |
| September 09, 2026 | 100.42M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Teva Pharmaceutical Industries Ltd. | 62.64B |
| RedHill Biopharma Ltd. | -11.74M |
| MediWound Ltd. | 158.09M |
| Purple Biotech Ltd. | -3.262M |
| Sol-Gel Technologies Ltd. | 129.48M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.754M |
| Total Expenses (Quarterly) | 5.754M |
| EPS Diluted (Quarterly) | -0.243 |
| Earnings Yield | -20.73% |
| Normalized Earnings Yield | -20.73 |